Cargando…
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
[Image: see text] Achievement of potent immunoresponses against self/tumor antigens and effective therapeutic outcome against advanced tumors remain major challenges in cancer immunotherapy. The specificity and efficiency of two nanoparticle-based delivery systems, lipid-calcium-phosphate (LCP) nano...
Autores principales: | Xu, Zhenghong, Wang, Yuhua, Zhang, Lu, Huang, Leaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004320/ https://www.ncbi.nlm.nih.gov/pubmed/24580381 http://dx.doi.org/10.1021/nn500216y |
Ejemplares similares
-
Nanoparticle-Delivered Transforming Growth Factor-β1 siRNA Induces PD-1 against Gastric Cancer by Transforming the Phenotype of the Tumor Immune Microenvironment
por: Wu, Fenglei, et al.
Publicado: (2022) -
Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
por: Xie, Xiaowei, et al.
Publicado: (2023) -
Retrovirus-delivered siRNA
por: Devroe, Eric, et al.
Publicado: (2002) -
Visualization of self-delivering hydrophobically modified siRNA cellular internalization
por: Ly, Socheata, et al.
Publicado: (2017) -
Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)